BAAR, Switzerland and MOUNTAIN VIEW, Calif -- atHeart Medical, a medical device company dedicated to establishing the new standard of care for closure of atrial septal defects (ASD), today announced ...
AtHeart Medical is moving on to the second phase of an IDE pivotal trial for its bioresorbable atrial septal defects occluder (ASD). The ASCENT ASD IDE trial is a 250- patient single-arm study that is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results